Season 2, Episode 10
Mar 11, 2021•17 min
Episode description
In this week’s episode, we will review recent studies providing new insights on frontline use of checkpoint inhibitors in classical Hodgkin lymphoma, immune escape mechanisms in diffuse large B-cell lymphoma, and the role of SRP54 mutations in congenital neutropenia.
For the best experience, listen in Metacast app for iOS or Android
